Gubra A/S

Copenhagen Stock Exchange GUBRA.CO

Gubra A/S Net Income for the year ending December 31, 2023: USD -6.59 M

Gubra A/S Net Income is USD -6.59 M for the year ending December 31, 2023, a -1,165.58% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Gubra A/S Net Income for the year ending December 31, 2022 was USD 618.49 K, a -94.04% change year over year.
  • Gubra A/S Net Income for the year ending December 31, 2021 was USD 10.38 M, a 399.47% change year over year.
  • Gubra A/S Net Income for the year ending December 31, 2020 was USD 2.08 M.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Copenhagen Stock Exchange: GUBRA.CO

Gubra A/S

CEO Mr. Henrik Blou
IPO Date April 4, 2023
Location Denmark
Headquarters Hørsholm Kongevej 11B
Employees 235
Sector Health Care
Industries
Biotechnology Pharmaceuticals Research & Consulting
Description

Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. The CRO segment offers pre-clinical contract research and development services for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, tissue research, assays, molecular pharmacology, bioanalysis, sequencing (NGS), and 2D and 3D imaging. The company was incorporated in 2008 and is based in Horsholm, Denmark.

StockViz Staff

January 15, 2025

Any question? Send us an email